tiprankstipranks
Trending News
More News >
Pharmaxis Ltd (AU:SNT)
ASX:SNT
Australian Market
Advertisement

Pharmaxis Ltd (SNT) Technical Analysis

Compare
14 Followers

Summary of all the Indicators

Overall Consensus
Buy
11Bullish
5Neutral
6Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Buy
8Bullish
0Neutral
4Bearish
Pharmaxis Ltd’s (SNT) Moving Averages Convergence Divergence (MACD) indicator is <0.01, suggesting Pharmaxis Ltd is a Sell.
Pharmaxis Ltd’s (SNT) 20-Day exponential moving average is 0.06, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Buy.
Pharmaxis Ltd’s (SNT) 50-Day exponential moving average is 0.06, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Buy.

Pharmaxis Ltd (SNT) Pivot Points

Aug 03, 2025, 12:35 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.05
0.06
0.06
0.06
0.06
0.07
0.07
Fibonacci
0.06
0.06
0.06
0.06
0.06
0.07
0.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Pharmaxis Ltd (SNT) Moving Averages

Aug 03, 2025, 12:35 PM
Period
Simple
Exponential
MA5
0.06Sell
0.06Buy
MA10
0.06Sell
0.06Buy
MA20
0.06Buy
0.06Buy
MA50
0.06Buy
0.06Buy
MA100
0.06Sell
0.06Buy
MA200
0.06Sell
0.06Buy
Pharmaxis Ltd’s (SNT) 10-Day exponential moving average is 0.06, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Buy.
Pharmaxis Ltd’s (SNT) 100-Day exponential moving average is 0.06, while Pharmaxis Ltd’s (SNT) share price is <AU$0.1, making it a Buy.
Pharmaxis Ltd’s (SNT) stock price is <AU$0.1 and Pharmaxis Ltd’s (SNT) 50-day simple moving average is 0.06, creating a Buy signal.
Pharmaxis Ltd’s (SNT) stock price is <AU$0.1 and Pharmaxis Ltd’s (SNT) 100-day simple moving average is 0.06, creating a Sell signal.
Pharmaxis Ltd’s (SNT) stock price is <AU$0.1 and Pharmaxis Ltd’s (SNT) 200-day simple moving average is 0.06, creating a Sell signal.

Pharmaxis Ltd (SNT) Technical Indicators

Aug 03, 2025, 12:35 PM
Name
Value
Implied Action
RSI (14)
69.85
Neutral
STOCH (9,6)
57.58
Neutral
STOCHRSI (14)
72.11
Neutral
MACD (12,26)
<0.01
Sell
ADX (14)
21.15
Neutral
Williams %R
-33.33
Buy
CCI (14)
119.88
Sell
ATR (14)
<0.01
-
Ultimate Oscillator
65.02
Neutral
ROC
20.00
Buy
Pharmaxis Ltd’s (SNT) Relative Strength Index (RSI) is 69.85, creating a Neutral signal.
Pharmaxis Ltd’s (SNT) Trend Strength Indicator (ADX) is 21.15, creating a Neutral signal.
Pharmaxis Ltd’s (SNT) Commodity Channel Index (CCI) is 119.88, creating a Sell signal.
Pharmaxis Ltd’s (SNT) Price Rate of Change (ROC) is 20.00, creating a Buy signal.

FAQ

Is SNT a Buy, Hold, or Sell?
Based on SNT’s technical indicators, SNT is a Buy.
    What is SNT’s RSI (14)?
    SNT’s RSI (14) is 69.85, which suggests SNT is a Neutral.
      What is SNT’s MACD?
      SNT’s MACD is <0.01, which suggests SNT is a Sell.
        What is SNT’s 5-day moving average?
        SNT’s 5-day moving average is 0.06, which suggests SNT is a Sell.
          What is SNT’s 20-day moving average?
          SNT 20-day moving average is 0.06, which suggests SNT is a Buy.
            What is SNT’s 50-day moving average?
            SNT’s 50-day moving average is 0.06, which suggests SNT is a Buy.
              What is SNT’s 200-day moving average?
              SNT’s 200-day moving average is 0.06, which suggests SNT is a Sell.
                What is SNT’s Williams % R (14)?
                SNT’s Williams % R (14) is -33.33, which suggests SNT is a Buy.
                  What is SNT’s CCI (14)?
                  SNT’s CCI (14) is 119.88, which suggests SNT is a Sell.
                    What is the share price of Pharmaxis Ltd?
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis